Back

Hybrid Stacking-Bagging Ensembles for Robust Multi-Omics Breast Cancer Prognosis

Bozorgpour, R.

2026-01-23 bioinformatics
10.64898/2026.01.21.700935 bioRxiv
Show abstract

Accurate breast cancer risk prediction remains a central challenge in precision oncology due to the complexity and heterogeneity of underlying biological processes. While single-modality models based on clinical, gene expression, or copy number variation (CNV) data provide valuable prognostic insights, they often fail to capture complementary information across data sources. Conventional stacking ensembles improve predictive performance through multimodal integration but remain susceptible to variance and overfitting. In this study, we propose a heterogeneous hybrid ensemble framework that combines stacking and bagging to enhance robustness and accuracy in multi-omics breast cancer classification. The framework integrates clinical features, gene expression profiles, and CNV data through stacked multimodal representations, followed by parallel stacking and bagging meta-learning and weighted fusion. Experiments conducted on the METABRIC cohort demonstrate that the proposed hybrid model achieves a ROC AUC of 0.9355, outperforming unimodal models (AUC range: 0.80-0.88) and a conventional stacking ensemble (AUC = 0.919). At the Youdens J optimal operating point, the hybrid approach yields balanced sensitivity (0.8571) and specificity (0.8792), with an overall accuracy of 87.4% and an F1-score of 0.7706. These results highlight the effectiveness of hybrid ensemble learning for robust multimodal integration and demonstrate its potential as a scalable and reliable approach for breast cancer risk prediction. The proposed framework offers a practical pathway toward improved predictive stability and supports the broader application of ensemble-based strategies in precision medicine.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

1
PLOS Computational Biology
1633 papers in training set
Top 5%
7.0%
2
Scientific Reports
3102 papers in training set
Top 15%
6.6%
3
npj Precision Oncology
48 papers in training set
Top 0.1%
5.0%
4
Briefings in Bioinformatics
326 papers in training set
Top 1%
5.0%
5
Bioinformatics
1061 papers in training set
Top 4%
5.0%
6
BMC Bioinformatics
383 papers in training set
Top 2%
4.4%
7
PLOS ONE
4510 papers in training set
Top 36%
4.0%
8
IEEE Journal of Biomedical and Health Informatics
34 papers in training set
Top 0.4%
3.7%
9
npj Systems Biology and Applications
99 papers in training set
Top 0.7%
2.4%
10
Computational and Structural Biotechnology Journal
216 papers in training set
Top 3%
2.2%
11
iScience
1063 papers in training set
Top 11%
1.9%
12
Frontiers in Genetics
197 papers in training set
Top 4%
1.9%
13
Advanced Science
249 papers in training set
Top 9%
1.9%
50% of probability mass above
14
Nature Communications
4913 papers in training set
Top 48%
1.9%
15
Computers in Biology and Medicine
120 papers in training set
Top 2%
1.8%
16
JCO Clinical Cancer Informatics
18 papers in training set
Top 0.4%
1.8%
17
Bioinformatics Advances
184 papers in training set
Top 3%
1.7%
18
Nucleic Acids Research
1128 papers in training set
Top 10%
1.7%
19
Cancers
200 papers in training set
Top 3%
1.5%
20
Cancer Research Communications
46 papers in training set
Top 0.5%
1.5%
21
International Journal of Molecular Sciences
453 papers in training set
Top 8%
1.5%
22
Frontiers in Molecular Biosciences
100 papers in training set
Top 3%
1.3%
23
Artificial Intelligence in Medicine
15 papers in training set
Top 0.4%
1.3%
24
Genome Medicine
154 papers in training set
Top 6%
1.3%
25
Journal of Pathology Informatics
13 papers in training set
Top 0.2%
1.1%
26
Journal of Chemical Information and Modeling
207 papers in training set
Top 2%
1.0%
27
BMC Medical Informatics and Decision Making
39 papers in training set
Top 2%
0.9%
28
Cancer Research
116 papers in training set
Top 3%
0.8%
29
Translational Oncology
18 papers in training set
Top 0.3%
0.8%
30
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 5%
0.8%